Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Invested Capital (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Invested Capital for 17 consecutive years, with $63.3 billion as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 3.78% to $63.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $63.3 billion through Dec 2025, down 3.78% year-over-year, with the annual reading at $63.3 billion for FY2025, 3.78% down from the prior year.
  • Invested Capital for Q4 2025 was $63.3 billion at Bristol Myers Squibb, down from $67.3 billion in the prior quarter.
  • The five-year high for Invested Capital was $85.2 billion in Q4 2023, with the low at -$1.5 billion in Q1 2023.
  • Average Invested Capital over 5 years is $49.2 billion, with a median of $51.0 billion recorded in 2024.
  • The sharpest move saw Invested Capital tumbled 115.44% in 2023, then surged 3667.21% in 2024.
  • Over 5 years, Invested Capital stood at $68.2 billion in 2021, then plummeted by 42.79% to $39.0 billion in 2022, then skyrocketed by 118.43% to $85.2 billion in 2023, then dropped by 22.76% to $65.8 billion in 2024, then dropped by 3.78% to $63.3 billion in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $63.3 billion, $67.3 billion, and $47.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.